medical and regulatory writing rare disease 3 Min Read How to Get an FDA Orphan Drug Designation By: Christine Clarke, PhD, Senior Global Regulatory Affairs Manager March 17, 2022
regulatory affairs rare disease FDA 2 Min Read New FDA Guidance to Support Ultra-Rare Disease Drug Development by Dr. Amanda Beaster, Senior Manager of Regulatory Strategy Antisense oligonucleotide ... January 10, 2022
medical and regulatory writing rare disease FDA 4 Min Read FDA Expedited Program Designations to Support Rare Disease Drug Development By: Christine Clarke PhD, Senior Medical Writer One in 10 Americans is affected by rare diseases—more than ... December 1, 2021
rare disease 4 Min Read Challenges of Rare Disease Drug Development Programs By: Amanda Beaster, Ph.D. September 15, 2021
News rare disease 2 Min Read PRO-BONO ULTRA-RARE DISEASE REGULATORY ASSISTANCE PROGRAM CREATED BY MMS FOR PATIENT ADVOCACY GROUPS WITH THE GREATEST NEED August 12, 2021
medical and regulatory writing regulatory affairs rare disease whitepaper 1 Min Read FDA Orphan Drug Designation Applications Whitepaper August 27, 2020
medical and regulatory writing regulatory affairs rare disease FDA 4 Min Read Developing Treatments for Rare Diseases – Reviewing Recent FDA Draft Guidances June 12, 2019
#OneMMS rare disease 4 Min Read How #OneMMS Actively Supports Rare Disease Day Rare diseases are often overlooked, but they affect many individuals. There may be as many as 7,000 rare ... February 27, 2019